Hydrocortisone / neomycin / polymyxin b otic Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Nov 23, 2022.
Hydrocortisone / neomycin / polymyxin b otic is also known as: AK-Spore HC Otic Suspension, Antibiotic Ear, Casporyn HC, Cort-Biotic, Cortatrigen, Cortatrigen Modified, Cortisporin Otic, Cortomycin, Drotic, Masporin Otic, Oti-Sone, Otimar, Otocort Sterile Solution, Otocort Sterile Suspension, Pediotic, UAD Otic
Hydrocortisone / neomycin / polymyxin b otic Pregnancy Warnings
Animal studies have shown this drug to be teratogenic. There are no adequate and well-controlled studies in pregnant women.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Use is not recommended.
US FDA pregnancy category: C
Hydrocortisone / neomycin / polymyxin b otic Breastfeeding Warnings
Use is not recommended.
Excreted into human milk: Hydrocortisone: Yes
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- "Product Information. Cortisporin Otic (hydrocortisone/neomycin/polymyxin B otic)." Monarch Pharmaceuticals Inc (2022):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
References for breastfeeding information
- "Product Information. Cortisporin Otic (hydrocortisone/neomycin/polymyxin B otic)." Monarch Pharmaceuticals Inc (2022):
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.